Trivarx Ltd has released a press release.
Converting Note & Non-Renounceable Entitlement Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Exclusive Agreement Signed for ilumen Pilot Program
- Response to ASX Appendix 4C Query
- Medibio Provides Update on FDA Process
- Medibio Appoints CEO and Managing Director
- MEB Signs ilumen Contract with Large Australian Employer
Later from TrivarX
- Ilumen Successfully Completes First Commercial Program
- Entitlement Issue Results and Shortfall Notification
- MEB Outsources Psychology Services in support of ilumen
- Sponsored Research Agreement with Humanitas University
- Regulatory and Commercialisation Strategy Update
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX